Lance-And-Sensor Combo Device Could Be Available To U.S. Diabetics In 2007
This article was originally published in The Gray Sheet
Pelikan Technologies says its purchase of Inventus BioTec puts the company on track to obtain 510(k) clearance for a fully integrated lance and glucose monitor in 2006, with a U.S. launch the next year
You may also be interested in...
Electronically controlled, fully automated lancing system will be unveiled at the June American Diabetes Association Scientific Sessions in New Orleans. Designed to reduce pain associated with blood sample collection, the device will launch in "early 2004" in the U.S., Pelikan Technologies says. The firm gained 510(k) clearance April 23. A second-generation system that combines the lancet with glucose measurement capability is expected in 2005...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.